From: Cancer incidence and mortality in Brunei Darussalam, 2011 to 2020
Cancer site | Male | Female | Both genders | ||||||
---|---|---|---|---|---|---|---|---|---|
Period | APC (95% CI) | p-value | Period | APC (95% CI) | p-value | Period | APC (95% CI) | p-value | |
(A) Incidence rate | Â | ||||||||
All cancer site | 2011–2020 | -0.2 (-2.3,1.9) | 0.813 | 2011–2020 | -0.2 (-3.0,2.7) | 0.858 | 2011–2017 2017–2020 | -2.1 (-3.6,-0.7) 4.6 (0.6,8.8) | 0.014* 0.030* |
Colorectal | 2011–2020 | 1.8 (-1.8,5.6) | 0.283 | 2011–2020 | -0.3 (-4.4,3.9) | 0.857 | 2011–2020 | 0.7 (-1.6,3.1) | 0.482 |
Lung and bronchus | 2011–2020 | -3.0 (-9.2,3.7) | 0.330 | 2011–2020 | -5.8 (-13.3,2.4) | 0.138 | 2011–2020 | -4.4 (-9.1,0.4) | 0.068 |
Prostate | 2011–2020 | 0.3 (-5.3,6.2) | 0.899 |  |  |  |  |  |  |
Non-Hodgkin lymphoma | 2011–2020 | -2.1 (-5.9,2.0) | 0.266 |  |  |  | 2011–2020 | -1.6 (-5.6,2.5) | 0.384 |
Liver | 2011–2020 | -1.5 (-6.6,3.9) | 0.531 |  |  |  | 2011–2020 | -0.9 (-7.0,5.5) | 0.744 |
Female breast |  |  |  | 2011–2020 | 0.5 (-2.1,3.2) | 0.676 |  |  |  |
Cervix |  |  |  | 2011–2020 | -4.5 (-7.1,-1.7) | 0.006* |  |  |  |
Corpus uteri |  |  |  | 2011–2020 | 13.3 (4.9,22.3) | 0.006* |  |  |  |
Stomach |  |  |  |  |  |  | 2011–2022 | -4.2 (-10.7,2.8) | 0.196 |
(B) Mortality rate | Â | ||||||||
All cancer site | 2011–2020 | -1.6 (-5.5,2.6) | 0.406 | 2011–2020 | -1.7 (-4.8,1.6) | 0.267 | 2011–2020 | -1.9 (-4.4,0.8) | 0.147 |
Lung and bronchus | 2011–2020 | -2.0 (-7.0,3.2) | 0.389 | 2011–2020 | -3.4 (-8.5,1.9) | 0.177 | 2011–2020 | -2.8 (-5.6,-0.1) | 0.055 |
Colorectal | 2011–2020 | -1.4 (-9.3,7.3) | 0.718 | 2011–2020 | -0.4 (-6.1,5.7) | 0.892 | 2011–2020 | -0.9 (-6.0,4.4) | 0.690 |
Liver | 2011–2020 | -4.5 (-10.8,2.2) | 0.157 |  |  |  | 2011–2020 | -3.1 (-8.0,2.0) | 0.197 |
Prostate | 2011–2020 | -0.7 (-9.2,8.6) | 0.855 |  |  |  |  |  |  |
Stomach | 2011–2020 | -2.0 (-10.4,7.3) | 0.629 |  |  |  | 2011–2020 | -4.7 (-9.2,-0.1) | 0.047* |
Female breast |  |  |  | 2011–2015 2015–2020 | 16.3 (9.0,24.1) -12.5 (-15.8,-9.1) | 0.002* < 0.001* |  |  |  |
Cervix |  |  |  | 2011–2020 | -1.8 (-12.5,10.2) | 0.728 |  |  |  |
Ovary |  |  |  | 2011–2020 | -4.5 (-11.6,3.2) | 0.206 |  |  |  |
Non-Hodgkin lymphoma |  |  |  |  |  |  | 2011–2022 | -1.1 (-8.9,7.3) | 0.754 |